Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 13, 2020
BD (Becton, Dickinson and Company) (NYSE: BDX), today issued the following statement after a White House meeting with CEOs of companies who have been involved in the effort to expand access to...
-
Mar 12, 2020
FRANKLIN LAKES, N.J. (March 12, 2019) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement: BD no longer manufactures or...
-
Mar 10, 2020CerTest Biotec launches CE Marked COVID-19 diagnostic test for the BD MAX™ System
CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the VIASURE SARS-CoV-2 Real Time PCR Detection Kit...
-
Mar 9, 2020
FRANKLIN LAKES, N.J. (March 9, 2020) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on a previously announced voluntary...
-
Mar 2, 2020
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Barclays Global Healthcare Conference on Wednesday, March...
-
Feb 27, 2020
SANTA BARBARA, Calif., Feb 27, 2020 -- Direct Relief, BD (Becton, Dickinson and Company) and the National Association of Free & Charitable Clinics (NAFC) today announced $125,000 in funding for...
-
Feb 20, 2020
FRANKLIN LAKES, N.J., February 20, 2020 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD Synapsys™ microbiology...
-
Feb 17, 2020BD Kiestra™ ReadA is device listed with the U.S. FDA
FRANKLIN LAKES, N.J., February 17, 2020 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the BD Kiestra™ ReadA is device...
-
Feb 13, 2020
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new, $6 million contract with the Fleming Fund, a U.K. aid program that helps low-...
-
Feb 12, 2020New capillary blood collection device combined with innovative sample handling and analytical technologies in clinical studies aim to make diagnostic blood testing more accessible and convenient
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and Babson Diagnostics, a transformative diagnostic blood testing company, today announced a long-term...


